Status:
COMPLETED
Infants With Agenesis of the Corpus Callosum
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Agenesis of the Corpus Callosum
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the neurological development at three years of age of children born after prenatal diagnosis of "isolated" agenesis of the corpus callosum.
Detailed Description
Agenesis of the corpus callosum is the most frequent brain malformation. This anomaly may be diagnosed by ultrasound screening. In half of these prenatal cases, the anomaly seems to be isolated. In th...
Eligibility Criteria
Inclusion
- Pregnant women from 28 weeks of gestation
- Complete agenesis of the corpus callosum
- Partial agenesis of the corpus callosum
- Abnormal corpus callosum (size, anatomy) As diagnosed by an expert ultrasound fetal brain examination.
Exclusion
- age \< 18 years old
- women who do not understand french
- women not covered by the French social security system
- refusal to participate
Key Trial Info
Start Date :
September 26 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 11 2022
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT02267161
Start Date
September 26 2015
End Date
January 11 2022
Last Update
September 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Armand Trousseau
Paris, France, 75012